BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 2378986)

  • 21. Chronic lymphocytic leukemia B cells inhibit spontaneous Ig production by autologous bone marrow cells: role of CD95-CD95L interaction.
    Sampalo A; Navas G; Medina F; Segundo C; Cámara C; Brieva JA
    Blood; 2000 Nov; 96(9):3168-74. PubMed ID: 11049999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of B-cell chronic lymphocytic leukaemia and hairy cell leukaemia like phenotypes by phorbol ester treatment of normal peripheral blood B-cells.
    Visser L; Poppema S
    Br J Haematol; 1990 Jul; 75(3):359-65. PubMed ID: 2386770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD5-positive B-cell malignancies frequently express cross-reactive idiotypes associated with IgM autoantibodies.
    Kipps TJ; Robbins BA; Tefferi A; Meisenholder G; Banks PM; Carson DA
    Am J Pathol; 1990 Apr; 136(4):809-16. PubMed ID: 1691593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunoglobulin V gene expression in CD5 B-cell malignancies.
    Kipps TJ; Rassenti LZ; Duffy S; Johnson T; Kobayashi R; Carson DA
    Ann N Y Acad Sci; 1992 May; 651():373-83. PubMed ID: 1376056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Examples of in vivo isotype class switching in IgM+ chronic lymphocytic leukemia B cells.
    Fais F; Sellars B; Ghiotto F; Yan XJ; Dono M; Allen SL; Budman D; Dittmar K; Kolitz J; Lichtman SM; Schulman P; Schuster M; Vinciguerra VP; Rai K; Stevenson FK; Gregersen PK; Ferrarini M; Chiorazzi N
    J Clin Invest; 1996 Oct; 98(7):1659-66. PubMed ID: 8833916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoire.
    Schroeder HW; Dighiero G
    Immunol Today; 1994 Jun; 15(6):288-94. PubMed ID: 7520700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between the expression of CD25 and CD69 on the surface of lymphocytes T and B from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia and established prognostic factors of this disease.
    Grywalska E; Bartkowiak-Emeryk M; Pasiarski M; Olszewska-Bożek K; Mielnik M; Podgajna M; Pieczykolan M; Hymos A; Fitas E; Surdacka A; Góźdź S; Roliński J
    Adv Clin Exp Med; 2018 Jul; 27(7):987-999. PubMed ID: 29893517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Malignant CD5 B cells--biased immunoglobulin variable gene usage and autoantibody production.
    Mayer R; Stone K; Han A; Bona C
    Int Rev Immunol; 1991; 7(3):189-203. PubMed ID: 1721931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of extensive mutations in the VH5 genes used in common B cell chronic lymphocytic leukemia.
    Rassenti LZ; Kipps TJ
    J Exp Med; 1993 Apr; 177(4):1039-46. PubMed ID: 7681468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural aspects of human IgM antibodies expressed in chronic B lymphocytic leukemia.
    Ramsland PA; Brock CR; Moses J; Robinson BG; Edmundson AB; Raison RL
    Immunotechnology; 1999 Mar; 4(3-4):217-29. PubMed ID: 10231091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autoantibody-encoding kappa L chain genes frequently rearranged in lambda L chain-expressing chronic lymphocytic leukemia.
    Rassenti LZ; Pratt LF; Chen PP; Carson DA; Kipps TJ
    J Immunol; 1991 Aug; 147(3):1060-6. PubMed ID: 1907304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth- and differentiation-associated expression of bcl-2 in B-chronic lymphocytic leukemia cells.
    Schena M; Larsson LG; Gottardi D; Gaidano G; Carlsson M; Nilsson K; Caligaris-Cappio F
    Blood; 1992 Jun; 79(11):2981-9. PubMed ID: 1375120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phorbol ester activates CD5+ leukaemic B cells via a T cell-independent mechanism.
    Tangye SG; Weston KM; Raison RL
    Immunol Cell Biol; 1995 Feb; 73(1):44-51. PubMed ID: 7539402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Variable region gene analysis of an isotype-switched (IgA) variant of chronic lymphocytic leukemia.
    Friedman DF; Moore JS; Erikson J; Manz J; Goldman J; Nowell PC; Silberstein LE
    Blood; 1992 Nov; 80(9):2287-97. PubMed ID: 1421400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of preactivated autologous T lymphocytes on CD80, CD86 and CD95 expression by chronic lymphocytic leukemia B cells.
    Romano C; De Fanis U; Sellitto A; Dalla Mora L; Chiurazzi F; Giunta R; Rotoli B; Lucivero G
    Leuk Lymphoma; 2003 Nov; 44(11):1963-71. PubMed ID: 14738151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autoantibody-associated cross-reactive idiotypes expressed at high frequency in chronic lymphocytic leukemia relative to B-cell lymphomas of follicular center cell origin.
    Kipps TJ; Robbins BA; Kuster P; Carson DA
    Blood; 1988 Aug; 72(2):422-8. PubMed ID: 3261179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunoglobulin genes in chronic lymphocytic leukemia.
    Kipps TJ
    Blood Cells; 1993; 19(3):615-25; discussion 631-2. PubMed ID: 8018942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Restriction of blood and marrow CLL-B cells to free L-chain Ig secretion: implication for normal B-cell function and control.
    Hopper JE; O'Brien J; Papagiannes E
    Am J Hematol; 1988 Nov; 29(3):125-33. PubMed ID: 3142253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The pathologic significance of the immunoglobulins expressed by chronic lymphocytic leukemia B-cells in the development of autoimmune hemolytic anemia.
    Efremov DG; Ivanovski M; Burrone OR
    Leuk Lymphoma; 1998 Jan; 28(3-4):285-93. PubMed ID: 9517500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biology of the neoplastic lymphocyte in B-CLL.
    Dighiero G
    Baillieres Clin Haematol; 1993 Dec; 6(4):807-20. PubMed ID: 8038491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.